And, although cholinergic cells appear to be spared in the LDT/PPT of AD patients, the presence of tau pathology in this region could instead lead to neurodegeneration of these GABAergic and glutamaterigic populations, which does not appear to have been previously examined. The gene discussed is MAPT; the disease is Alzheimer disease.